about this reel

What DSIP Reviews Is

DSIP Reviews is a systematic reading of the peer-reviewed research literature on Delta Sleep-Inducing Peptide (DSIP, Emideltide) — the record organized to show what the evidence supports and where it stops. It is no clinic and keeps no clinicians; it prescribes nothing and gives no medical guidance; it makes, sells, and ships nothing. What it produces is a review of the published literature, nothing more.

The domain name uses the word 'reviews' in the same sense that a scientific journal uses it: a systematic review of the literature, organized to help readers understand what the published evidence actually shows — including its limits. The modifier is editorial framing, not a claim about any service the site offers.

Editorial Standards

Every quantitative claim on this site is cited to a specific peer-reviewed publication, official regulatory record, or primary database. Citations use PubMed IDs and DOIs where available; every citation on the /references page links directly to the primary source.

Where the evidence is limited, inconsistent, or contested — and the DSIP literature has significant areas of all three — the text says so explicitly. The controversies and limitations discussed on /research and /faq are not hedging language added to satisfy disclaimers; they are part of the honest account of what the literature shows.

We use compound names only — no brand names, no trademark references. We do not reference other domains in this publisher's portfolio on Phase 1 pages.

What we do not do:

• Invent or fabricate research findings
• Provide dosage recommendations for any human application
• Imply any affiliation with researchers, institutions, or vendors cited in the literature
• Endorse any vendor, product, or compounding pharmacy
• Provide any form of medical, clinical, or therapeutic consultation

Why DSIP?

The DSIP research record is genuinely interesting from an editorial standpoint — and genuinely underrepresented in accessible English-language coverage. A peptide isolated in 1974 from rabbit cerebral venous blood during electrically-induced sleep, carrying effects across sleep architecture, withdrawal medicine, neuroendocrinology, antioxidant biology, mitochondrial protection, and stroke recovery, with an upcoming FDA advisory committee review in July 2026: that is a five-decade scientific arc worth indexing clearly.

Most of what you find when you search for DSIP online is either incomplete, promotional, or framed for an audience that is not particularly interested in what the peer-reviewed record actually shows. This site is for researchers, students, science journalists, and general readers who want an indexed, cited summary of the literature without commercial framing.

Disclaimer

DSIP (Emideltide) is not approved by the FDA for any therapeutic indication and is classified as a research chemical in the United States. The content on this site is a systematic reading of research already in the public record — it is not medical advice, clinical guidance, or a recommendation of any kind.

This publication makes, sells, and ships nothing, and holds no tie to any vendor, compounding pharmacy, or research institution. Readers with health concerns are directed to a licensed clinician.